Karnataka, India

Abhisek Banerjee


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022-2025

where 'Filed Patents' based on already Granted Patents

6 patents (USPTO):

Title: Innovations by Abhisek Banerjee: Pioneering Research in Cancer Treatment

Introduction

Abhisek Banerjee is an innovative inventor based in Karnataka, India. With a focus on pharmaceutical advancements, he has secured three patents that contribute significantly to the field of cancer treatment.

Latest Patents

His latest innovations include groundbreaking patents for KIF18A inhibitors, which are compounds designed to modulate the KIF18A protein. This modulation influences the cell cycle and cell proliferation, presenting new avenues for treating cancer and cancer-related diseases. This invention encompasses pharmaceutical compositions that utilize these compounds and methods for addressing disease states linked to KIF18A activity. Additionally, he has developed N-cyano-7-azanorbornane derivatives, offering unique therapeutic uses and methods of manufacturing compounds that have broad applications in pharmacy.

Career Highlights

Abhisek Banerjee currently works for Amgen Inc., a well-respected biotechnology company known for its innovations in medicine. His work at Amgen has allowed him to explore complex biochemical pathways and develop novel treatments that can potentially change the landscape of cancer therapy.

Collaborations

Throughout his career, Banerjee has collaborated with esteemed colleagues including Nuria A Tamayo and Jian Jeffrey Chen. These collaborations have further enhanced his research efforts, leading to significant advancements in understanding therapeutic compounds.

Conclusion

Abhisek Banerjee's contributions to the field of cancer research are noteworthy. His innovative patents not only demonstrate his commitment to advancing medical science but also offer hope for improved treatments for patients battling cancer. As he continues his work at Amgen, the impact of his inventions is anticipated to expand further in the realm of pharmaceutical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…